A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.

It's an unusual winter for respiratory illnesses. The flu is peaking twice: once in early January and again in February.

Hopkins researchers help secure full FDA approval to treat immunocompromised COVID-19 patients—paving the way to explore ...